Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology worldwide. The company's principal products include Aranesp and EPOGEN that stimulate the production of red blood cells to treat anemia; Neulasta and NEUPOGEN, which selectively stimulate the production of ...

Preventing tranfusion-transmitted infection is what Chiron is all about. As the world leader in blood safety for the transfusion industry, we develop novel tools, products and services to protect the global blood supply.

Chiron is the blood screening business of Novartis Vaccines and Diagnostics, a division of Novartis AG that was created in 2006 following the acquisition of Novartis Vaccines and Diagnostics.